Alvotech Humira Settlement Sets Up Interchangeable Adalimumab Showdown
US Launch Date Matches That Of BI’s Cyltezo Interchangeable Humira Biosimilar
• By David Wallace
Alvotech and Boehringer Ingelheim could launch rival interchangeable Humira biosimilars on the same date • Source: Thomas LENNE / Alamy Stock Photo 
